HIGHLIGHTS
- who: Translocator Protein et al. from the Weifang Medical University, Weifang, China have published the research: Translocator Protein 18kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain, in the Journal: Neural Plasticity of 29/08/2022
- what: In the studies described herein, expression of proinflammation factors like IL-1β, IL-6, and CXCL1 is decreased after overexpression or activation of TSPO, further validating the role of TSPO in the inhibition of the neuroinflammatory response.
SUMMARY
Chronic pain is a major public health issue, which seriously affects patients' quality of life . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.